Publicacions en col·laboració amb investigadors/es de Centro de Investigación Médica Aplicada (27)

2019

  1. Improvement of appropriate pharmacological prophylaxis in hospitalised cancer patients with a multiscreen e-alert system: a single-centre experience

    Clinical and Translational Oncology, Vol. 21, Núm. 6, pp. 805-809

2018

  1. Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study

    PLoS ONE, Vol. 13, Núm. 8

2017

  1. EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth

    Journal of Hematology and Oncology, Vol. 10, Núm. 1, pp. 1-12

  2. Inducing heat shock protein 70 expression provides a robust antithrombotic effect with minimal bleeding risk

    Thrombosis and Haemostasis, Vol. 117, Núm. 9, pp. 1722-1729

2016

  1. Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk

    Cardiovascular Research, Vol. 110, Núm. 3, pp. 309-318

  2. Identification of new markers of recurrence in patients with unprovoked deep vein thrombosis by gene expression profiling: the retro study

    European Journal of Haematology, Vol. 97, Núm. 2, pp. 128-136

  3. Short Leukocyte Telomere Length Is Associated with Cardioembolic Stroke Risk in Patients with Atrial Fibrillation

    Stroke, Vol. 47, Núm. 3, pp. 863-865

2015

  1. Protein C system defects inflicted by the malaria parasite protein PfEMP1 can be overcome by a soluble EPCR variant

    Thrombosis and Haemostasis, Vol. 114, Núm. 5, pp. 1038-1048

2014

  1. Laparoscopic limited liver resection decreases morbidity irrespective of the hepatic segment resected

    HPB, Vol. 16, Núm. 4, pp. 320-326

2013

  1. Matrix metalloproteinase-10 plays an active role in microvascular complications in type 1 diabetic patients

    Diabetologia, Vol. 56, Núm. 12, pp. 2743-2752

2012

  1. Atrial fibrillation in pigs induces left atrial endocardial transcriptional remodelling

    Thrombosis and Haemostasis, Vol. 108, Núm. 4, pp. 742-749

  2. Is EPCR a multi-ligand receptor? Pros and cons

    Thrombosis and Haemostasis, Vol. 107, Núm. 5, pp. 815-826

  3. Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma

    American Journal of Respiratory and Critical Care Medicine, Vol. 186, Núm. 1, pp. 96-105

  4. Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study)

    American Journal of Cardiology, Vol. 109, Núm. 1, pp. 95-99

2011

  1. Factor X and factor VII binding to endothelial protein C receptor differs between species

    Journal of Thrombosis and Haemostasis

  2. Limited ability to activate protein C confers left atrial endocardium a thrombogenic phenotype: A role in cardioembolic stroke?

    Stroke, Vol. 42, Núm. 9, pp. 2622-2624

  3. The endothelial cell protein C receptor: Its role in thrombosis

    Thrombosis Research, Vol. 128, Núm. 5, pp. 410-416

2010

  1. Blocking endothelial protein C receptor (EPCR) accelerates thrombus development in vivo

    Thrombosis and Haemostasis, Vol. 103, Núm. 6, pp. 1239-1244

  2. The endothelial cells downregulate the generation of factor VIIa through EPCR binding

    British Journal of Haematology, Vol. 149, Núm. 1, pp. 111-117

  3. VEGF121b and VEGF165b are weakly angiogenic isoforms of VEGF-A

    Molecular Cancer, Vol. 9